{"result": "(\"entity\"<|>AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS<|>ORGANIZATION<|>The American Association of Clinical Endocrinologists (AACE) provides guidelines for the diagnosis and management of thyroid nodules and related conditions.)\n##\n(\"entity\"<|>NATIONAL COMPREHENSIVE CANCER NETWORK<|>ORGANIZATION<|>The National Comprehensive Cancer Network (NCCN) develops clinical practice guidelines in oncology, including those for thyroid carcinoma.)\n##\n(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association (ATA) issues management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer.)\n##\n(\"entity\"<|>KOREAN SOCIETY OF THYROID RADIOLOGY<|>ORGANIZATION<|>The Korean Society of Thyroid Radiology provides consensus statements and recommendations for the ultrasonography diagnosis and management of thyroid nodules.)\n##\n(\"entity\"<|>BENNEDBAEK FN<|>PERSON<|>Bennedbaek FN is a researcher who contributed to the study of treatment for recurrent thyroid cysts.)\n##\n(\"entity\"<|>HEGEDÜS L<|>PERSON<|>Hegedüs L is a researcher involved in the treatment and management of thyroid conditions.)\n##\n(\"entity\"<|>Gharib H<|>PERSON<|>Gharib H is a researcher who has contributed to the guidelines for the management of thyroid nodules.)\n##\n(\"entity\"<|>HADDAD RI<|>PERSON<|>Haddad RI is a contributor to the NCCN Clinical Practice Guidelines in Oncology for thyroid carcinoma.)\n##\n(\"entity\"<|>NA DG<|>PERSON<|>Na DG is a researcher who has worked on radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers.)\n##\n(\"entity\"<|>PERROS P<|>PERSON<|>Perros P is a researcher involved in the guidelines for the management of thyroid cancer.)\n##\n(\"entity\"<|>VERDE G<|>PERSON<|>Verde G is a researcher who has studied ultrasound-guided percutaneous ethanol injection in the treatment of cystic thyroid nodules.)\n##\n(\"relationship\"<|>AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS<|>NATIONAL COMPREHENSIVE CANCER NETWORK<|>Both organizations provide guidelines for the management of thyroid conditions, indicating a collaborative or related focus in their work.<|>7)\n##\n(\"relationship\"<|>AMERICAN THYROID ASSOCIATION<|>NATIONAL COMPREHENSIVE CANCER NETWORK<|>Both organizations develop clinical practice guidelines for thyroid-related conditions, showing a connection in their objectives.<|>7)\n##\n(\"relationship\"<|>KOREAN SOCIETY OF THYROID RADIOLOGY<|>AMERICAN THYROID ASSOCIATION<|>Both organizations provide guidelines and recommendations for the management of thyroid nodules, indicating a shared interest in thyroid health.<|>7)\n##\n(\"relationship\"<|>BENNEDBAEK FN<|>HEGEDÜS L<|>Both researchers contributed to the study of treatment for recurrent thyroid cysts, indicating a collaborative research effort.<|>6)\n##\n(\"relationship\"<|>Gharib H<|>HADDAD RI<|>Both researchers have contributed to the guidelines for the management of thyroid nodules and cancer, indicating a shared focus in their work.<|>6)\n##\n(\"relationship\"<|>NA DG<|>VERDE G<|>Both researchers have worked on treatments related to thyroid nodules, indicating a connection in their research interests.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ica de los nódulos tiroideos, dependiendo de su tamaño y riesgo ecográfico de malignidad:\n\n• En caso de sospecha elevada o intermedia de malignidad en la ecografía tiroidea se recomienda punción aspirativa con aguja fina (PAAF) de los nódulos mayores o iguales de 1 cm.\n• En caso de sospecha baja, se recomienda realizar PAAF en los nódulos mayores de 1,5 cm.\n• Y en caso de sospecha muy baja, se recomienda realizar opcionalmente en nódulos mayores de 2 cm.\n• Finalmente, en los nódulos claramente benignos (puramente quísticos) no está indicado realizar PAAF.\n\nRecomendaciones similares se efectúan en otras guías, como las de la American Association of Clinical Endocrinologists (AACE), National Comprehensive Cancer Network (NCCN), y las Sociedades de Endocrinología británica y coreana.\n\nEn cuanto a la indicación de la PAAF en nódulos entre 0,5 y 1 cm de diámetro, las guías de la ATA lo recomiendan en casos de extensión extratiroidea y metástasis ganglionares o a distancia, recomendación que también aparece en las guías de la AACE. Así pues, la opción D es correcta.\n\nIgualmente son correctas las opciones B y C. En efecto, la evacuación del contenido quístico de un nódulo tiroideo es una opción terapéutica firmemente establecida desde hace muchos años en nódulos puramente quísticos.\n\nUna opción de tratamiento de los nódulos tiroideos son las terapias mínimamente invasivas, como es la ablación por radiofrecuencia u otras tecnologías similares. Sin embargo, antes de indicar estas técnicas es preciso haber demostrado la benignidad del nódulo, para lo que se requiere su estudio citológico previo, incluso en dos ocasiones.\n\nReferencias:\n• Bennedbaek FN, Hegedüs L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab. 2003;88:5773-7.\n• Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules--2016 Update. Endocr Pract. 2016;22:622-39.\n• Haddad, RI, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Thyroid Carcinoma Version 1. © 2016 National Comprehensive Cancer Network, Inc; 2016. Available at NCCN.org\n• Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.\n• Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13:117-25.\n• Nabhan F, Ringel MD. Thyroid Nodules and Cancer Management Guidelines: Comparisons and Controversies. Endocr Relat Cancer. 2017;24:R13-26.\n• Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81:1-122.\n• Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol. 2016;17:370-95.\n• Verde G, Papini E, Pacella CM, Gallotti C, Delpiano S, Strada S, et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf). 1994;41:719-24.\n\n## 33. Indique cuál de los siguientes factores no se ha implicado en la patogenia del bocio difuso no tóxico:\n\nA. Deficiencia de yodo.\nB. Ciertos haplotipos de HLA que incrementan el riesgo de autoinmunidad tiroidea.\nC. Exposición a ciertos factores ambientales como la deficiencia de selenio.\nD. Estímulo por la TSH.\n\n## COMENTARIO\n\nLa aparición de un bocio difuso no tóxico se considera un proceso adaptativo del tiroides a cualquier factor que dificulta la síntesis de hormonas tiroideas. El yodo, por su relativa escasez en la naturaleza, es el principal factor limitante en la\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}